Antitumor activity of bis-indole derivatives

Journal of Medicinal Chemistry

Volumn 51, Issue 15, 2008, Pages 4563-4570

  Andreani, Aldo ^a   Burnelli, Silvia ^a   Granaiola, Massimiliano ^a   Leoni, Alberto ^a   Locatelli, Alessandra ^a   Morigi, Rita ^a   Rambaldi, Mirella ^a   Varoli, Lucilla ^a   Landi, Laura ^a   Prata, Cecilia ^a   Berridge, Michael V ^b   Grasso, Carole ^b   Fiebig, Heinz Herbert ^c   Kelter, Gerhard ^c   Burger, Angelika M ^d   Kunkel, Mark W ^e  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^c CHARLES RIVER LABORATORIES   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIACETYL 3 6 (INDOL 3 YLMETHYLENE)PIPERAZINE 2,5 DIONE; 3,6 (INDOL 3 YLMETHYLENE)PIPERAZINE 2,5 DIONE; 3,6 (OXO 1,2 DIHYDROINDOL 3 YLIDENE)PIPERAZINE 2,5 DIONE; ANTINEOPLASTIC AGENT; INDOLE DERIVATIVE; PIPERAZINE; PROTEASOME; PYRIDINE; RITA; SUNITINIB; TAS 202; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DRUG MECHANISM; DRUG SYNTHESIS; ELECTRON TRANSPORT; ENZYME INHIBITION; HEALTH CARE ORGANIZATION; HOLLOW FIBER; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; INDOLES; MOLECULAR STRUCTURE; NEOPLASMS; UBIQUITIN-PROTEIN LIGASES;

EID: 49449118144     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm800194k     Document Type: Article

References (39)

1. Potential Antitumor Agents. 43 (hawks-1). For part 42, see the following: Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Calonghi, N.; Cappadone, C.; Farruggia, G.; Zini, M.; Stefanelli, C.; Masotti, L.; Radin N. S.; Shoemaker, R. H. New Antitumor Imidazo[2,1-b]thiazole Guanylhydrazones and Analogues. J. Med. Chem. 2008, 51, 809-816.
2. Andreani, A.; Rambaldi, M.; Bonazzi, D.; Lelli, G.; Bossa, R.; Galatulas, I. Substituted Imidazo[2,1-b]thiazoles and Thiazolines as Potential Cardiotonic Agents. Eur. J. Med. Chem. 1984, 19, 219-222.
3. Andreani, A.; Rambaldi, M.; Locatelli, A.; Bossa, R.; Galatulas, I.; Ninci, M. Synthesis and Cardiotonic Activity of 2-Indolinones. Eur. J. Med. Chem. 1990, 25, 187-190.
4. Andreani, A.; Locatelli, A.; Rambaldi, M.; Leoni, A.; Bossa, R.; Fraccari, A.; Galatulas, I. Potential Antitumor Agents. 25. Synthesis and Cytotoxic Activity of 3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones. Anticancer Res. 1996, 16, 3585-3588.
5. von Dobeneck, H.; Wolkenstein, D.; Blankenstein, G. α, β′-Diindolylmethane und -methene Der Urorosein-Chromophor. Chem. Ber. 1969, 102, 1347-1356.
6. Kobayashi, G.; Matsuda, Y.; Tominaga, Y.; Ohkuma, M.; Shinoda, H.; Kohno, M.; Mizuno, D. Antitumor Activity of Indole Derivatives. Yakugaku Zasshi 1977, 97, 1033-1039.
7. Buzzetti, F.; Pinciroli, V.; Brasca, M. G.; Crugnola, A.; Fustinoni, S.; Longo, A. Synthesis and Configuration of Some New Bicyclic 3-Arylidene- and 3-Heteroarylidene-2-oxindoles. Gazz. Chim. Ital. 1995, 125, 69-75.
8. Andreani, A.; Locatelli, A.; Leoni, A.; Morigi, R.; Chiericozzi, M.; Fraccari, A.; Galatulas, I.; Salvatore, G. Synthesis and Potential Coanthracyclinic Activity of Pyridylmethylene and Indolylmethylene Lactams. Eur. J. Med. Chem. 1998, 33, 905-909.
9. Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Garaliene, V. Synthesis and Antitumor Activity of 1,5,6-Substituted 3-(2-chloro-3-indolylmethylene) 1,3-dihydroindol-2-ones. J. Med. Chem. 2002, 45, 2666-2669.
10. Andreani, A.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Garaliene, V.; Farruggia, G.; Masotti, L. Substituted E-3-(2-Chloro-3-indolylmethylene)1,3-dihydroindol-2-ones with Antitumor Activity. Bioorg. Med. Chem. 2004, 12, 1121-1128.
11. Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Calonghi, N.; Cappadone, C.; Farruggia, G.; Zini, M.; Stefanelli, C.; Masotti, L. : Substituted E-3-(2-Chloro-3- indolylmethylene)1,3-dihydroindol-2-ones with Antitumor Activity. Effect on the Cell Cycle and Apoptosis. J. Med. Chem. 2007, 50, 3167-3172.
12. Andreani, A.; Rambaldi, M.; Leoni, A.; Locatelli, A.; Bossa, R.; Chiericozzi, M.; Dambrosio, M.; Galatulas, I. Synthesis and Cardiotonic Activity of 2-Indolinones Bearing Pyridyl groups. Eur. J. Med. Chem. 1993, 28, 653-657.
13. Andreani, A.; Leoni, A.; Locatelli, A.; Morigi, R.; Chiericozzi, M.; Fraccari, A.; Galatulas, I. Potential Coanthracyclinic Activity of Pyridylmethylene-2-indolinones. Anticancer Res. 1998, 18, 3407-3410.
14. Tanaka, K.; Konno, Y.; Kuraishi, Y.; Kimura, I.; Suzuki, T.; Kiniwa, M. Synthesis of a Magnosalin Derivative, 4-(3,4,5-Trimethoxyphenyl)-6-(2,4,5- trimethoxyphenyl)-2-diethylaminopyrimidine, and the Anti-Angiogenic and Anti-Rheumatic Effect on Mice by Oral Administration. Bioorg. Med. Chem. Lett. 2002, 12, 623-627.
15. Doggrell, S. A. RITA - A Small-Molecule Anticancer Drug That Targets p53. Expert Opin. Invest. Drugs 2005, 14, 739-742.
16. Barlaam, B.; Bird, T. G.; Lambert-van der Brempt, C.; Campbell, D.; Foster, S. J.; Maciewicz, R. New r-Substituted Succinate-Based Hydroxamic Acids as TNFr Convertasi Inhibitors. J. Med. Chem. 1999, 42, 4890-4908.
17. Katritzky, A. R.; Fan, W.-Q.; Szajda, M.; Li, Q.-L.; Caster, K. C. Conjugated Systems Derived from Piperazine-2,5-dione. J. Heterocycl. Chem. 1988, 25, 591-597.
18. Pauli, K. D.; Lin, C. M.; Malspeis, L.; Hammel, E. Identification of Novel Antimitotic Agents Acting at the Tubulin Level by Computer-Assisted Evaluation of Differential Cytotoxicity Data. Cancer Res. 1992, 52, 3892-3900.
19. Burger, A.; Amemiya, Y.; Kitching, R.; Seth, A. K. Novel RING E3 Ubiquitin Ligases in Breast Cancer. Neoplasia 2006, 8, 689-695.
20. Connor, M. K.; Azmi, P. B.; Subramaniam, V.; Li, H.; Seth, A. Molecular Characterization of Ring Finger Protein 11. Mol. Cancer Res. 2005, 3, 453-461.
21. Herst, P. M.; Berridge, M. V. Plasma Membrane Electron Transport: A New Target for Cancer Drug Development. Curr. Mol. Med. 2006, 6, 895-904.
22. Herst, P. M.; Petersen, T.; Jerram, P.; Baty, J.; Berridge, M. V. The Antiproliferative Effects of Phenoxodiol Are Associated with Inhibition of Plasma Membrane Electron Transport in Tumour Cell Lines and Primary Immune Cells. Biochem. Pharmacol. 2007, 74, 1587-1595.
23. Hollingshead, M.; Alley, M. C.; Camalier, R. F.; Abbott, B. J.; Mayo, J. G.; Malspeis, L.; Grever, M. R. In Vivo Cultivation of Tumor Cells in Hollow Fibers. Life Sci. 1995, 57, 131-141.
24. Alley, M. C.; Hollingshead, M. G.; Dykes, D. J.; Waud, W. R. Human Tumor Xenograft Models in NCI Drug Development. In Cancer Drug Discovery and Development: Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, 2nd ed.; Teicher, B. A., Andrews, P. A., Eds.; Humana Press Inc.: Totowa, NJ, 2004; Chapter 7.
25. Plowman, J.; Dykes, D. J.; Hollingshead, M.; Simpson-Herren, L.; Alley, M. C. Human Tumor Xenograft Models in NCI Drug Development. In Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval; Teicher, B., Ed.; Humana Press Inc.: Totowa, NJ, 1997, Chapter 6.
26. Beer, R. J. S.; Davenport, H. F.; Robertson, A. Extensions of the Synthesis of Hydroxyindoles from p-Benzoquinones. J. Chem. Soc. 1953, 1262-1264.
27. Nakagawa, K.; Sato, T.; Nishi, T.; Oshiro, Y.; Yamamoto, K. Carbostyril and Oxindole Derivatives. JKXXAF JP 52073866 19770621 Showa (patent written in Japanese); Application JP 75-150935 19751216, CAN 87:167899 AN 1977:567899 CAPLUS, 1977; 5 pp, Jpn. Kokai Tokkyo Koho.
28. Minisci, F.; Galli, R.; Cecere, M. Amminazione Radicalica di Composti Aromatici Attivati: Acetammidi. Nuovo Processo per la Sintesi di para-Ammino-N,N-dialchilaniline. Chim. Ind. 1966, 48, 1324-1326.
29. Zakrzewska, A.; Kolehmainen, E.; Osmialowski, B.; Gawinecki, R. 4-Fluoroanilines: Synthesis and Decomposition. J. Fluorine Chem. 2001, 111, 1-10.
30. Hidenori, O.; Shigeharu, T.; Takafumi, F.; Shuji, T.; Kazumi, K.; Shuji, Y.; Youichi, Y.; Michiaki, T.; Kazuyuki, N. Studies on Positive Inotropic Agents. Synthesis of I-Heteroaroylpiperazine Derivatives. Chem. Pharm. Bull. 1988, 36, 2253-2258.
31. Sun, L.; Tran, N.; Tang, F.; App, H.; Hirth, P.; McMahon, G.; Tang., C. Synthesis and Biological Evaluations of 3-Substituted Indolin-2-ones: A Novel Class of Tyrosine Kinase Inhibitors That Exhibit Selectivity toward Particular Receptor Tyrosine Kinases. J. Med. Chem. 1998, 41, 2588-2603.
32. Andreani, A.; Rambaldi, M.; Bonazzi, D.; Greci, L.; Andreani, F. Hydrazone Derivatives of 5-Substituted 2-Chloro-3-formyl-6-methylindole. Farmaco 1979, 34, 132-138.
33. Porter, J. C.; Robinson, R.; Wyler, M. Monothiophthalimide and Some Derivatives of Oxindole. J. Chem. Soc. 1941, 620-624.
34. Monks, A.; Scudiero, D.; Skehan, P.; Shoemaker, R.; Pauli, K.; Vistica, D.; Hose, C.; Langley, J.; Cronise, P.; Vaigro-Wolff, A. Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines. J. Natl. Cancer Inst. 1991, 83, 757-766.
35. Roth, T.; Burger, A. M.; Dengler, W.; Willmann, H.; Fiebig, H. H. Human Tumor Cell Lines Demonstrating the Characteristics of Patient Tumors as Useful Models for Anticancer Drug Screening. Contrib. Oncol. 1999, 54, 145-156.
36. Fiebig, H. H.; Dengler, W. A.; Roth, T. Human Tumor Xenografts: Predictivity, Characterization, and Discovery of New Anticancer Agents. Contrib. Oncol. 1999, 54, 29-50.
37. Fiebig, H. H.; Berger, D. P.; Dengler, W. A.; Wallbrecher, E.; Winterhalter, B. R. Combined in Vitro/in Vivo Test Procedure with Human Tumor Xenografts Contrib. Oncol. 1992, 42, 321-351.
38. Dengler, W. A.; Schulte, J.; Berger, D. P.; Mertelsmann, R.; Fiebig, H. H. Development of a Propidium Iodide Fluorescence Assay for Proliferation and Cytotoxicity Assay. Anti-Cancer Drugs 1995, 6, 522-532.
39. Burger, A. M.; Gao, Y.; Amemiya, Y.; Kahn, H. J.; Kitching, R.; Yang, Y.; Sun, P.; Narod, S. A.; Hanna, W. M.; Seth, A. K. A Novel RING-Type Ubiquitin Ligase Breast Cancer-Associated Gene 2 Correlates with Outcome in Invasive Breast Cancer. Cancer Res. 2005, 65, 10401-10412.